Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
5
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
spinal muscular atrophy
5
×
texas blog main
texas top stories
5
×
wisconsin blog main
wisconsin top stories
biogen
biotech
fda
medicare
novartis
clinical trials
eli lilly
gene therapy
parkinson's disease
startups
alexion pharmaceuticals
alzheimer's disease
astrazeneca
What
bio
roundup
alzheimer’s
democrats
drug
ipo
prices
week
allogene
america
annual
assessed
attention
biogen
biotech
cancer
communities
companies
conference
congress
continues
convoluted
crispr
different
diversity
divided
dreams
elections
esmo
europe
fail
fallout
gene
germany
head
headaches
healthcare
holding
hosted
hot
Language
Current search:
photo
×
" detroit top stories "
×
" spinal muscular atrophy "
×
" texas top stories "
×
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More